Hyperglycosylated Mutants of Human Immunodeficiency Virus (HIV) Type 1 Monomeric gp120 as Novel Antigens for HIV Vaccine Design
The ability to induce broadly neutralizing antibodies should be a key component of any forthcoming vaccine against human immunodeficiency virus type 1. One potential vaccine candidate, monomeric gp120, has generally failed to elicit such antibodies. We postulated that gp120 might be a better immunog...
Na minha lista:
| Publicado no: | J Virol |
|---|---|
| Principais autores: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Microbiology (ASM)
2003
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC154011/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12719582/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.77.10.5889-5901.2003 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|